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ABSTRACT (max 350 words) 
Background: Affective dysregulation is widely regarded as being the core problem in patients with 
borderline personality disorder (BPD). Moreover, BPD is the disorder mainly associated with affective 
dysregulation. However, the empirical confirmation of the specificity of affective dysregulation for BPD is 
still pending. We used a validated approach from basic affective science that allows for simultaneously 
analyzing three interdependent components of affective dysregulation that are disturbed in patients with 
BPD: homebase, variability, and attractor strength (return to baseline).  
Methods: We applied two types of multilevel models on two e-diary datasets to investigate group 
differences regarding three subcomponents between BPD patients (n=43; n=51) and patients with 
posttraumatic stress disorder (PTSD; n=28) and those with bulimia nervosa (BN; n=20) as clinical control 
groups in dataset 1, and patients with panic disorder (PD; n=26) and those with major depression (MD; 
n=25) as clinical control groups in dataset 2. In addition, healthy controls (n=28; n=40) were included in the 
analyses. In both studies, e-diaries were used to repeatedly collect data about affective experiences during 
participants’ daily lives. In study 1 a high-frequency sampling strategy with assessments in 15 minute-
intervals over 24 hours was applied, whereas the assessments occurred every waking hour over 48 hours in 
study 2. The local ethics committees approved both studies, and all participants provided written informed 
consent. 
Results: In contradiction to our hypotheses, BPD patients did not consistently show altered affective 
dysregulation compared to the clinical patient groups. The only differences in affective dynamics in BPD 
patients emerged with regard to one of three subcomponents, affective homebase. However, these results 
were not even consistent. Conversely, comparing the patients to healthy controls revealed a pattern of more 
negative affective homebases, higher levels of affective variability, and (partially) reduced returns to 
baseline in the patient groups. 
Conclusions: Our results indicate that affective dysregulation constitutes a transdiagnostic 
mechanism that manifests in similar ways in several different mental disorders. We point out promising 
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prospects that might help to elucidate the common and distinctive mechanisms that underlie several different 
disorders and that should be addressed in future studies. 
 
Keywords: Borderline personality disorder, affective dysregulation, specificity, e-diary, electronic 
diary, ambulatory assessment 
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INTRODUCTION 
Affective dysregulation is widely regarded as being the core problem in patients with Borderline 
Personality Disorder (BPD) and the driving force behind the severe clinical manifestations of BPD 
symptoms. This is supported by a magnitude of empirical findings relating affective dysregulation to other 
BPD symptoms and behaviors [1–3]. The importance of affective dysregulation is furthermore delineated in 
the DSM-5 [4] and the ICD-10 [5], since several diagnostic criteria for BPD, such as, e.g., affective 
instability, intense anger, and chronic feelings of emptiness directly reflect aspects of dynamic affective 
difficulties. In one of the most highly regarded theories of BPD, the biosocial theory [6], the affective 
dysregulation emerges from transactions between biological vulnerabilities and specific environmental 
influences. According to this model the affective dysregulation in BPD manifests in: (a) a high sensitivity to 
emotional stimuli (especially negative ones) resulting in a lower threshold for responding to those; (b) 
intense responses to emotional stimuli, i.e., emotional responses with greater amplitudes; and in (c) a longer 
duration of emotional responses and thus a slow return to baseline after responding to emotional stimuli. In a 
nutshell, affective dysregulation is of central importance in this disorder and has had major impacts on 
theory, research, and treatment. However, most recently Santangelo et al. [7] used an electronic diary 
approach to clarify the specificity of affective instability in BPD, and largely failed. BPD patients showed 
comparable affective instability to patients with posttraumatic stress disorder (PTSD) and patients with 
bulimia nervosa (BN), which raised the question to consider subcomponents of affective dynamics. 
To further clarify the unsatisfying findings regarding the specificity of affective instability and to 
delineate differences in emotional processes between patients with BPD and clinical controls, Ebner-Priemer 
et al. [8] proposed the use of the DynAffect model [9], i.e., a model from basic affective science. The 
DynAffect model synthesizes different lines of basic research on emotion dynamics into one coherent model 
with the objective of identifying the major processes that underlie individual differences in the temporal 
dynamics of affective experiences [9]. It assumes three components which characterize individual 
differences in affect dynamics. These postulated components can be mapped to the three subcomponents of 
affective dysregulation defined in the biosocial theory of BPD [6] as shown above: (a) affective homebase, 
Specificity of Affective Dysregulation for BPD 
5 
 
i.e., an individual baseline attractor state around which affect fluctuates; (b) level of affective variability, i.e., 
the fluctuations around the homebase that result from responses to internal or external processes or events; 
and (c) attractor strength, i.e., regulatory or homeostatic processes that pull deviating affective fluctuations 
back toward the homebase and thus enables emotional recovery. Dysregulated affect can become expressed 
in several ways in the three DynAffect components. First, negative deviations from a normative affective 
homebase that is mildly positive and aroused [10] can be indicative of affect dysregulation. Second, high 
levels of affect variability are related to lower psychological well-being [11], and are considered to be, at 
least to some extent, the result of disrupted emotion regulation [12]. Third, high attractor strength reflects 
successful affect regulation with affective experience being strongly pulled back to the homebase, whereas 
low attractor strength indicates affect that keeps lingering, suggestive of failing affect regulation efforts [13]. 
Ebner-Priemer et al. [8] empirically validated the appropriateness of the DynAffect model in 
examining affective dysregulation in BPD by statistically modeling data from three e-diary studies 
containing data of patients with BPD and healthy subjects. This validation showed strong support for more 
negative affective homebases and heightened affective variabilities as well as partial support of a slower 
return to baseline in BPD patients compared to healthy controls, both with regard to valence as well as 
distress. Thus, Ebner-Priemer et al. [8] presented a theoretical model that captures the most fundamental 
affective dynamical processes that are supposed to underlie BPD and showed the usefulness of this model by 
applying it to multiple empirical datasets. However, the question regarding the specificity of the three 
subcomponents of affective dysregulation was not addressed in this study, since the datasets did not include 
any clinical control groups.  
To address the still open question whether affective dysregulation is specific for patients with BPD 
or whether affective dysregulation rather constitutes a transdiagnostic feature of several mental disorders, we 
simultaneously analyzed the three subcomponents of affective dysregulation (homebase, variability, and 
attractor strength). We analyzed two independent datasets to investigate whether BPD patients show a 
specific pattern of affective dysregulation as proposed by the biosocial theory of BPD [6]. We compared 
BPD patients (n=43 and n=51) with clinical control groups consisting of patients with PTSD (n=28) and 
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with BN (n=20) in dataset 1, and patients with panic disorder (PD; n=26) and with major depression (MD; 
n=25) in dataset 2. In both studies, e-diaries were used to repeatedly collect data about affective experiences 
(valence and distress) during participants’ daily lives. In study 1 we applied a high-frequency sampling 
strategy with assessments of momentary valence and distress in 15 minute-intervals over 24 hours during 
waking time. In the second study, we utilized a sampling strategy with repeated assessments of current 
distress every waking hour over 48 hours. We applied two types of multilevel models to simultaneously 
analyze the subcomponents of affective dysregulation [8] as proposed by the biosocial theory [6]. Due to the 
predictions derived from the biosocial theory, we hypothesized (a) a more negative affective homebase in 
the BPD group compared to the clinical control groups; (b) BPD patients to exhibit heightened affective 
variability in comparison to the clinical control groups; and (c) that the patients with BPD would exhibit 
reduced attractor strength (i.e., a higher autocorrelation reflecting a slower return to baseline) compared to 
the clinical control groups. In addition, we included healthy control participants in the analyses to check 
robustness of the results.  
 
METHODS 
Participants: Dataset 1 
A total sample of 119 female participants between 18 and 48 years of age was investigated: 43 
patients with BPD, 28 patients with PTSD, 20 patients with BN and 28 healthy controls. Data were collected 
at the Central Institute of Mental Health Mannheim and the Psychosomatic Clinic St. Franziska-Stift Bad 
Kreuznach in Germany. Outpatients and inpatients were recruited from their outpatient clinics or wards or 
via advertisements in local newspapers and on the internet. The healthy controls were selected randomly 
from the national resident register of the City of Mannheim or recruited via advertisement. The participants’ 
sample characteristics are summarized in Table 1. For further details about the dataset, please consult the 
publication of Santangelo et al. [7] describing the specific aspects of it. With regard to this dataset, statistical 
analyses of other characteristics have been reported. In details, the specificity of global instability [7] as well 
as first analyses regarding subcomponents of affective dysregulation comparing BPD patients to healthy 
controls [8]. However, the main research question of the current paper, namely if subcomponents of 
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affective dysregulation show specificity for BPD patients compared to clinical controls, have not been 
analyzed or reported before.  
 
Participants: Dataset 2 
Sample 2 consists of 142 female participants between 17 and 50 years of age: 51 BPD patients, 26 
PD patients, 25 MD patients and 40 healthy controls. Data were collected at the Freiburg University Medical 
School and at the Free University of Berlin, both located in Germany. Outpatients and inpatients were 
recruited from their outpatient clinics and private practices or wards, respectively. The healthy controls were 
randomly selected from the national resident register of the City of Freiburg. The sample characteristics are 
shown in Table 1. For a more detailed description of the dataset, please consult the publication of Stiglmayr 
et al. [15]. There are no previous publications on this data set with regard to affective instability or affective 
dysregulation as in dataset 1.  
 
Diagnostic Procedure: Dataset 1 and 2 
All patients met the DSM-IV criteria for their specific disorder. In both samples, Axis I disorders were 
assessed using the German version of the Structured Clinical Interview for DSM-IV Axis I Disorders 
(SCID-I; [16]), and Axis II disorders were assessed using the German versions of the International 
Personality Disorder Examination (IPDE; [17]) in dataset 1 and the BPD section of the Structured Clinical 
Interview for DSM-IV Axis II Disorders (SCID-II; [18]) in dataset 2, respectively. In the healthy control 
group, the absence of any current or past Axis I or Axis II disorder diagnoses was confirmed by the SCID-I 
and SCID-II. Trained postgraduate psychologists administered all diagnostic instruments. In the patient 
groups, a history of schizophrenia or bipolar disorder or current substance abuse constituted exclusion 
criteria. Furthermore, patients of the clinical control groups who met the criteria for BPD were excluded in 
both studies. All other comorbidities were allowed in the patient groups. The exclusion criteria for the 
healthy controls included any current or past Axis I or Axis II disorder diagnoses, self-reported current 
psychotherapy, or the current use of psychotropic medications. As Table 1 shows, patients with BPD had 
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very high rates of comorbid Axis I disorders, particularly eating disorder, anxiety disorders, and depressive 
disorders in both datasets. Whereas patients with PTSD and those with BN had similar high rates of 
comorbid eating, anxiety, and depressive disorders in dataset 1, the patients with PD and those with MD had 
lower rates of comorbidities, at least with regard to eating disorders in dataset 2. 
 
PLEASE INSERT TABLE 1 HERE 
 
Data Collection Procedure: Datasets 1 
All participants provided written informed consent prior to participation in the study, which has been 
approved by the local ethics committee. Participants were carefully instructed and trained regarding the use 
of the palmtop computer (Tungsten E, Palm Inc., U.S.A.). To function as e-diaries the palmtop computers 
were programmed with the DialogPad software (Gerhard Mutz, Cologne University, Germany). Subsequent 
to the training session, participants carried the e-diary for 24 hours. The e-diary emitted a prompting signal 
every 15 minutes (±1 minute) during the waking time. Questions regarding the participants’ current 
emotions followed each prompt. Participants were asked “Do you feel any of the following emotions right 
now?” followed by the list of happy, anxious, angry, shame, disgust, sad, guilt, interest, envy/jealousy, 
emotion but cannot name it, and no emotion. After selecting a current emotional state, participants rated the 
intensity of this emotion on an 11-point Likert scale ranging from 1 to 11. In case that “emotion but cannot 
name it” was chosen, an additional question was added concerning the pleasantness of the current emotion 
(pleasant or unpleasant) followed by the intensity rating. In addition, participants rated their current intensity 
of distress on an 11-point Likert scale from 0 to 10. After the 24-hour assessment period participants 
returned the device and the data were downloaded from the e-diaries. 
 
Data Collection Procedure: Datasets 2 
The local ethics committees approved the study, and all participants provided written informed 
consent before participating. Participants attended an orientation session to get familiar with the use of the 
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palmtop computer (Psion 3a, Psion PLC, United Kingdom). The palmtop computers were programmed with 
the MONITOR software [19] to emit a prompting signal in hourly intervals (±5 minutes). Participants 
carried the e-diary over a 48-hour period and were prompted every hour during waking time to provide 
information regarding their current subjective distress experience on a single 10-point Likert scale ranging 
from 0 to 9. After the 48-hour assessment period participants returned the devices and the data were 
downloaded from the e-diaries.  
 
Compliance: Dataset 1 and 2 
Compliance in both datasets was very high (94% and 92%, respectively). Participants in dataset 1 
provided on average 57.55 (Sd=7.77; Median=57) self-reports, whereas participants in dataset 2 provided on 
average 25.37 (Sd=3.58; Median=26) momentary assessments (Table 1; for a more detailed description of 
compliance see Santangelo et al. [7] for dataset 1 and Stiglmayr et al. [15] for dataset 2). 
 
DATA PREPROCESSING AND STATISTICAL ANALYSES 
Data preprocessing 
To aggregate the separate assessments of emotion and intensity into a single valence index in dataset 
1, the intensities of negative emotions were multiplied by -1, and the intensities of the positive emotions 
retained positive values [7]. This method resulted in valence scores with a range of -11 to +11. Ratings of 
“no emotion” were given valence scores of zero. Thus, the two dependent variables used in the statistical 
analyses were (a) valence (with possible values ranging from -11 to +11) and (b) distress (with possible 
values ranging from 0 to 10). No data preprocessing was necessary in dataset 2. Possible values of distress 
as the dependent variable ranged from 0 to 9. 
For the subcomponents analysis of distress, data from one BPD patient and one PTSD patient and 
eight healthy controls were excluded from the analyses due to lack of variability or linear trend in their 
ratings in dataset 1. The final sample for this analysis consisted of 42 BPD patients, 27 patients with PTSD, 
20 patients with BN and 20 healthy controls. No participants were excluded in the analysis of valence in this 
dataset. In dataset 2, two patients with MD and seven healthy controls were excluded from the analyses due 
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to lack of variability in their distress ratings. Thus, the final sample consisted of 51 BPD patients, 26 patients 
with PD, 23 patients with MD and 33 healthy controls. 
 
Statistical analyses 
We used multilevel modeling to analyze the three subcomponents of affective dysregulation: (a) 
affective homebase (i.e., one’s affective baseline state), (b) affective variability (i.e., the total sum of the 
fluctuations around the affective homebase in response to internal or external events), and (c) attractor 
strength (i.e., the regulatory processes that pull affect back to its homebase or return to baseline). These 
statistical approaches were used to simultaneously model the three different parameters and to investigate 
how these parameters differed as functions of group (BPD vs. PTSD vs. BN and BPD vs. PD vs. MD, 
respectively).  
The main analyses were performed using HLM [20]. To test our hypotheses, a total of three models 
with the BPD group as the reference group were tested (i.e., one model with valence and one with distress as 
outcome variables in dataset 1 and one model with distress as the outcome variable in dataset 2). The 
multilevel regression analyses models were defined as follows (with the BPD patients as the reference 
group): 
Level 1 equation: 
distressti =π0i + π1i*distress(t-1)i + eti  
Level 2 equation: 
π0i = β00 + β01*(PTSDi) + β02*(BNi)  + r0i   
π1i = β10 + β11*(PTSDi) + β12*(BNi) + r1i   
Var(R) = σ2 and log(σ2) = α0 + α1(PTSDi) + α2(BNi) 
where distressti corresponds to the distress rating for person i at time t. At level 1, distressti is 
predicted by a random intercept and a time-lagged version of itself (i.e., distress(t-1)i). This variable has been 
centered around the person mean (i.e., within-person centered) and previous-day observations were set as 
missing to exclude day-to-day carry-over effects. The random slope of this lagged variable, π1i, is the 
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autoregressive effect of distress(t-1)i on distressti. At level 2, the random intercept and slope are both 
predicted by an intercept and two dummy variables coding for the clinical control groups. The equation 
shown is the multilevel model comparing the BPD group (as the reference group it is not represented by a 
dummy variable) to the PTSD group and the BN group. β00 corresponds to the mean distress, i.e., the 
distress homebase, in the BPD group (when the PTSD and BN dummies are equal to zero). Similarly, β10 
corresponds to the mean autoregressive slope, i.e., the return to baseline, in the BPD group (when the two 
dummy coded group variables are zero). Simultaneously, the within-person variance is modeled as a 
function of the two dummy variables. For the examination of valence, distressti was replaced by valenceti 
(dataset 1). For the analyses in dataset 2 the dummy variables coding for the clinical groups were replaced 
(i.e., PTSDi and BNi were replaced by PDi and MDi). Additionally, we estimated three models with the same 
outcome variables, this time examining general differences between healthy controls and clinical groups. 
More specifically, we estimated a multilevel model with the healthy controls as the reference group and a 
dummy coding for all patients taken together (i.e., the healthy controls vs. BPD+PTSD+BN in dataset 1, and 
the healthy controls vs. BPD+PD+MD in dataset 2, respectively). 
Last, in order to enable the identification of consistent patterns of results and to allow for robust 
conclusions we repeated all analyses with slightly different models and in a different statistical framework. 
These models are extensions of the models used before, in that not only the intercept and the autoregressive 
slope but also the within-person variance was estimated as a random effect. In other words, we allowed for 
individual differences in within-person variances, while the models described above assume that the within-
person variance is homogenous within diagnostic groups. The statistical inference for these models was 
done using Bayesian statistics instead of the frequentist statistical approach that is adopted in the models 
described above. Bayesian statistics requires the specification of priors. For each person the model has a 
person-specific intercept, slope and within-person variance (the latter is log-transformed). The triplet of 
person-specific parameters is assumed to come from a trivariate normal population distribution. This 
trivariate distribution has a population mean for each parameter that may differ across the clinical groups. 
We used dummy coding schemes to incorporate these group differences. Both for the reference group mean 
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as for the deviations of the other groups, we assumed as priors relative vague normal distributions with mean 
being zero and variance being 1000 (for the autocorrelation, the normal prior distributions were truncated at 
-1 and 1). The variance-covariance matrix of the trivariate normal distribution was the same for all groups 
and its prior was an inverse-Wishart with an identity matrix as scale matrix and four degrees of freedom. 
The Bayesian analyses were implemented in JAGS [21]. We used four chains with a burn-in period of 5000 
iterations. The subsequent 2500 iterations from each chain were used for inference (no thinning). 
Convergence of the chains was checked for the different parameters visually (i.e., by looking at the trace 
plots and the autocorrelation graphs), and numerically (i.e., by calculating the shrink factor) [22, 23]. The 
trace plots were stationary time series, and they overlapped for different chains, while the autocorrelation 
plots did not indicate any strong autocorrelation. For all parameters, the shrink factor was very close to 1 
(and always below 1.1). Taken together, these diagnostics suggest good convergence. Moreover, based on 
these additional models applied in the Bayesian framework we also constructed density plots (see Figure 1A, 
1B, and 1C). For each specific parameter (i.e., homebase, variability, and attractor strength), we first 
estimated the posterior mean per person and then we made a density plot for each group based on these 
posterior means, showing the (posterior) distributions of the parameters of interest for each investigated 
group separately.  
 
RESULTS 
Subcomponent affective homebase 
Results from the multilevel regression models are shown in Table 2. These indicated that the distress 
level of the homebase of the BPD patients was comparable to that of the PTSD and BN patients in dataset 1 
(HOMEBASE, π0, Table 2). BPD patients and those with PTSD also had homebases characterized by 
similar levels of unpleasantness, whereas the BPD patients had a homebase that was marginally significantly 
more negative compared to the BN patients. Using multilevel models applied in the Bayesian framework, no 
differences were found between BPD and the clinical groups for both the valence and the distress dimension 
of the homebase (i.e., the marginally significant difference between the BPD and the BN patients with 
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regard to valence was not robust). In dataset 2, the BPD patients had a homebase with significantly higher 
distress levels compared to the PD and MD patients, which was confirmed by the models applied in the 
Bayesian framework. 
Moreover, patients showed a homebase with significantly higher levels of distress compared to 
healthy controls in dataset 1 and 2 (HOMEBASE, π0, Table 3). Furthermore, the healthy controls tended to 
have a pleasant valence homebase, whereas the clinical groups, patients with BPD, those with PTSD and 
those with BN were, on average, characterized by a significantly more unpleasant or negative valence 
homebase in dataset 1. All results were in line with the conclusions from the multilevel models with 
Bayesian inference. 
The distributions of the affective homebase parameters for all groups in dataset 1 and 2 are depicted 
in the density plots shown in Figure 1A. Descriptively, the impressive differences between the healthy 
controls and the clinical groups hit the eye in all three figures of Figure 1A. For healthy controls the plots 
are more located to the left for distress in both datasets (indicating lower distress levels), and more to the 
right for valence (reflecting a more positive homebase). Moreover, the estimates are more homogenous 
within the healthy control sample, as the plots are less wide. In contrast, only minor differences among the 
clinical groups seem to emerge, with the only exception of the distribution of the homebase parameters for 
distress in dataset 2. The plot for the BPD patients is located more to the right and is broader, reflecting 
higher levels of distress and more heterogeneity within the BPD sample. 
Subcomponent within-person variability 
Results showed that the within-person variability (VARIANCE, Table 2) of distress in the BPD 
patients was comparable to that of the PTSD patients (dataset 1) and the PD and MD patients (dataset 2). 
The BN patients in dataset 1 had a significantly elevated variability of distress compared to the BPD 
patients, albeit this significant difference was not robust (since the results of the models with Bayesian 
inference indicated no difference of within-person variability of distress between BN and BPD patients). 
With regard to the variability of valence no significant differences between BPD patients and PTSD or BN 
patients was evident, which was supported by the results of the multilevel models with Bayesian inference. 
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The results for the variability of distress and valence revealed significant differences between healthy 
controls and all patient groups. Patients with BPD and those with PTSD and with BN showed significantly 
higher within-person variability of distress as well as valence compared to healthy controls in dataset 1 
(VARIANCE, Table 3). Heightened variability in distress compared to the healthy subjects was also found 
in patients (those with BPD, those with PD and those with MD) in dataset 2. Again, these results were in 
line with the conclusions from the multilevel models with Bayesian inference. 
On a descriptive basis, clear differences emerged between the healthy controls and the clinical 
groups in the density plots in Figure 1B. The density plots for the healthy controls are again located more to 
the left, reflecting lower average within-person variance for this group. However, the differences between 
the clinical groups seem negligible. 
Subcomponent attractor strength (return to baseline) 
No differences emerged comparing the attractor strength between the clinical groups, neither 
between the BPD group and the PTSD and BN patients (dataset 1) nor between the BPD group and the PD 
and MD patients (dataset 2) and neither regarding attractor strength in distress nor valence 
(AUTOREGRESSIVE slope, π1, Table 2). 
The results regarding attractor strength of distress indicate a significantly lower autoregressive slope 
(i.e., higher attractor strength and thus faster return to baseline) in the healthy controls compared to BPD, 
PTSD and BN patients (AUTOREGRESSIVE slope, π1, Table 3) in dataset 1. The result from the model 
with Bayesian inference is in line with this finding. In dataset 2, marginally significantly higher attractor 
strength in distress was found in the healthy controls when compared to the patient groups. However, this 
difference was not found in the models applied in the Bayesian framework. For valence, we only found 
marginally significantly higher attractor strength for healthy controls in comparison to the patient groups. 
Again, this difference was not found in the models with Bayesian inference. 
The density plots for the attractor strength component are not as clear as those for the other two 
components, since the distributions of the healthy controls do not seem to clearly stand out (see Figure 1C). 
The only exception is the plot for the attractor strength parameter for distress in dataset 1, since the 
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distribution for healthy controls is slightly more located to the left (indicating higher attractor strength). 
With regard to differences between the clinical groups, there are only slight differences between the 
distributions of the attractor strength estimates. 
 
PLEASE INSERT TABLE 2 AND TABLE 3 HERE 
PLEASE INSERT FIGURE 1 HERE 
 
DISCUSSION 
To further clarify the specificity of affective dysregulation in BPD, we used a recently proposed 
model of affective dynamics (the DynAffect model) simultaneously modeling three central subcomponents 
of affective dysregulation (homebase, variability, and attractor strength). Contrary to our expectations, BPD 
patients did not consistently show a specific pattern of affective dysregulation compared to other clinical 
groups (i.e., patients with PTSD, with BN, with PD and with MD). Therefore, our results indicate that 
affective dysregulation is, apart from very few exceptions, not very specific for BPD, as the clinical groups 
tended to show similar results. In dataset 1 we found no robust differences (i.e., consistent differences 
between the groups in both types of multilevel analyses) neither regarding the distress level of the 
homebases nor the valence dimension of the homebases of the BPD patients and the PTSD and BN patients. 
Furthermore, we did not find consistent results regarding elevated affective variability nor slower return to 
baseline in the BPD patients compared to either patient group, i.e., PTSD and BN patients (dataset 1) or PD 
and MD patients (dataset 2). The only robust exception (i.e., with consistent findings in both types of 
multilevel models) where patients with BPD showed altered affective dynamics compared to the clinical 
controls was: the BPD patients had a homebase with significantly higher levels of distress compared to the 
PD and the MD patients (dataset 2). Thus, the only differences emerged with regard to one of three 
subcomponents. Furthermore, the results regarding the homebase component were not perfectly consistent, 
since: (a) differences regarding the distress dimension of the homebase were only found in dataset 2 (i.e., the 
PD and the MD patients), but not in dataset 1 (i.e., the PTSD and BN patients); and (b) no differences 
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regarding the valence dimension of the homebase emerged. Taken together, our results do not show 
specificity of affective dysregulation regarding several components of affective dysregulation (i.e., 
homebase, variability, and attractor strength) for patients with BPD. Instead, our results can be interpreted as 
further empirical evidence for affective dysregulation manifesting in similar ways in several different 
disorders that are characterized by affective disturbances. 
Of course, BPD is the disorder mainly associated with affective dysregulation and there is even a 
BPD journal with emotion dysregulation it its title. However, there are multiple theoretical 
conceptualizations which associate a variety of mental disorders with affective dysregulation, i.e., some kind 
of burdensome affective experience, deficient affect regulation, or dysfunctional affect regulation behavior 
[24–28]. This is in line with the idea that affect regulation is an essential component to mental health [9, 29] 
and an important risk and maintaining factor in various mental disorders [30], and that affect regulation 
strategies are included as treatment modules across numerous disorders, e.g., eating disorders [31, 32], 
depressive disorders [33], and PTSD [34]. Taken together, these results might be interpreted as an indication 
that affective dysregulation rather constitutes a transdiagnostic feature that emerges in several mental 
disorders. Moreover, the differences between the patient groups and the healthy controls regarding all three 
subcomponents of affective dysregulation are greatly consistent, both for distress and valence. In a similar 
vein, prior studies investigating the specificity of affective instability for BPD revealed mixed findings 
regarding heightened instability in BPD compared to clinical controls. While several diary studies found 
heightened affective instability in BPD compared to patients with depressive disorders [35–37], no 
differences were found between BPD patients and patients with PTSD [7], those with BN or with anorexia 
nervosa [7, 38], patients with premenstrual dysphoric syndrome [35], or other personality disorders [39]. 
Therefore, global instability indices were not able to clearly differentiate the clinical groups and thus 
instability did not show sufficient specificity. Due to the unexpected nature of these findings analyzing 
subcomponents of the dynamic processes in order to delineate existing differences in emotional processes 
between patients with BPD and clinical controls has been proposed recently [7, 8]. However, this could not 
resolve inconsistencies as we have shown in the present paper. Thus, even though we used state of the art 
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assessment (e-diaries) and analytic methods (multilevel modeling) as well as two comprehensive datasets 
(N=119 and N=142) we did not find clear group differences regarding the subcomponents of affective 
dysregulation between BPD patients and patients with PTSD, those with BN, those with PD and those with 
MD as clinical control groups.  
As we can exclude with reasonable certainty that subcomponent analyses reveal specificity of 
affective dysregulation for BPD there are, on a methodological level, two more main topics that should be 
considered to differentiate affective processes between disorders [7, 27]: (a) events and triggers of emotional 
episodes are rarely assessed, but are very likely to differ between disorders (a notable exception in BPD is 
[40]). E.g., tempting food might trigger affective processes in patients with BN, but not in patients with 
PTSD, whereas for traumatic memories the opposite pattern might be expected. Moreover, context plays a 
central role in emotion regulation [41, 42]. Therefore, contextual factors should be systematically 
incorporated into the study of emotion dysregulation in future studies.; (b) the appraisal of affective 
processes might be worthy of examination, since affective changes that are accompanied by changes in self-
esteem (a further diagnostic criterion for BPD) might be experienced as more threatening [7]. Thus, the 
association between affective instability and self-esteem instability in patients with BPD might differ (and 
therefore be specific for BPD) from those with other psychiatric disorders. This association between 
affective dysregulation and self-esteem instability in patients with BPD and those with other psychiatric 
disorders should be investigated in future studies. 
On top of that, undifferentiated affect or emotional granularity has been discussed as being an 
essential component of the affect regulation process [43, 44]. However, its potential to show specificity of 
altered affect in BPD patients seems rather limited, since a recent study showed that the experience of 
undifferentiated affect probably constitutes a transdiagnostic mechanism and might be likely relevant to a 
range of disorders [45]. 
 
Limitations and methodological particularities 
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Some limitations of our study should be mentioned. We used electronic diaries to investigate 
affective dysregulation in participants’ everyday lives. This comes along with the disadvantage that the 
control of confounding variables is limited. Even though laboratory studies offer the possibility of testing 
hypotheses under the most rigorous control, they nonetheless do so under artificial, laboratory conditions, 
which may account for differences between the laboratory and real life [46–48]. Investigating affective 
dysregulation in everyday life has the crucial advantage that it renders experimental symptom induction 
unnecessary: it is studied in the context where it naturally occurs, in patients’ everyday life [49]. Studies that 
have examined affective dysregulation in BPD in the laboratory have produced inconsistent findings, which 
might be explained by the affect induction methods used in these studies [8]. A further advantage of e-diary 
assessments is that retrospective single assessments such as questionnaires or interviews are not suited to 
investigate dynamic processes, such as affective dysregulation [27, 49–52]. By utilizing e-diary methods one 
can repeatedly assess the variable of interest in real time and therefore actually track the ebb and flow of 
affective states.  
When investigating affective dynamics using e-diaries, it is of primary importance that the sampling 
rate matches the temporal dynamics of the underlying target process [27, 49, 53]. Both a sampling rate that 
is too infrequent (which might miss the dynamics of interest) as well as a sampling rate that is too frequent 
(which might overburden participants without increasing insights since the information is irrelevant) is 
problematic [14]. Even though guidelines regarding the sampling frequency are rare, there is a general 
consensus that the sampling interval must fit the temporal dynamics of the target processes [53, 54]. In our 
two datasets the time-based designs differed. Assessments occurred every 15 minutes in datasets 1, and 
every hour in dataset 2. Since the conclusions were largely similar across both datasets, the assessment 
methods do not seem to have substantially influenced the results. Moreover, we are confident that both 
sample designs were appropriate to assess the affective dynamics, since it has been empirically shown that a 
sampling interval of less than 1 hour captures a specific process, whereas the data yielded by low frequency 
sampling rates (i.e., 2 hour intervals and longer) cannot be distinguished from random data [53]. 
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Even though both the assessment method and the sample frequencies are appropriate to investigate 
affective dynamics, the cross-sectional design of study 1 and 2 renders it impossible to evaluate the 
importance of the affective dysregulation in the long term. We determined the three subcomponents of 
affective dysregulation only during 24 hours and 48 hours, respectively. Thus, we got only a snapshot of 
affective dysregulation. This is adequate to analyze group differences regarding affective dysregulation; 
however, it is inappropriate to investigate potential associations between affective dysregulation and long 
term variables, such as level of functioning and symptom severity, psychopathology, or treatment outcome. 
Therefore, longitudinal studies allowing for the investigation of the predictive value of affective 
dysregulation are clearly needed. 
A further limitation is the rather small sample sizes of the clinical control groups in both datasets. 
Even though both datasets were extensive (N=119 and N=142, respectively), this was mainly due to large 
group sizes of the BPD patients and the healthy controls. With regard to the clinical groups, the group sizes 
of 28 patients with PTSD, 20 patients with BN and 26 PD patients and 25 MD patients are low and larger 
sample sizes are needed to replicate findings. However, prior studies analyzed group differences based on as 
small group sizes as 15 patients with BPD and four patients with anorexia nervosa [38], or 16 patients with 
BPD, 10 patients with MD and 15 patients with premenstrual dysphoric syndrome [35]. Moreover, the 
patient groups in both datasets differed in their hospitalization rates. However, no differences in symptom 
severity between hospitalized and non-hospitalized patients emerged (see Santangelo et al. [7] for dataset 1 
and Stiglmayr et al. [15] for dataset 2). Furthermore, because only female participants were included in both 
datasets, the generalizability of the findings is constrained and the results may not be valid for male BPD 
patients. However, the use of a pure female sample also reduced heterogeneity, which may be useful given 
the literature on sex differences on affect [55]. In study 1 and 2 BPD diagnoses were made using different 
diagnostic instruments, i.e., IPDE [17] in study 1 and SCID-II [18] in study 2. However, both diagnostic 
instruments are well-validated with very good psychometric properties and good interrater reliability [17, 
18]. Moreover, the two datasets were analyzed separately and independently, thus, diagnoses and group 
comparisons are valid within each study. Patients, especially BPD patients, in both datasets were diagnosed 
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with a variety of comorbid disorders. Given the finding that comorbidity might alter affective dysregulation 
[56] no statement can be made on whether our findings are independent of any comorbidity. However, in 
BPD comorbidity is the rule rather than the exception [57] and therefore, only BPD patients with comorbid 
disorders are seen as representative for the BPD population [58]. 
 
Conclusions 
In summary, using sophisticated behavioral science research methodology and validated analytic 
techniques we were unable to reveal a specific pattern of affective dysregulation in patients with BPD 
compared with clinical controls (i.e., patients with PTSD, those with BN, those with PD or those with MD). 
Even though affective dysregulation is widely regarded as being the core problem in patients with BPD and 
BPD being the disorder mainly associated with affective dysregulation, our results are in accordance with 
clinical observations and reports that most psychological disorders show some kind of affective 
dysregulation. Taken together, these findings suggest that affective dysregulation might be an important 
clinical characteristic of several disorders, in the sense of a transdiagnostic symptom or risk factor. 
Nonetheless, the possibility of evaluating the importance of a construct such as affective instability in a 
cross-sectional study is clearly restricted. Longitudinal studies allowing for the investigation of the 
predictive value of affective dysregulation might reveal group differences. Thus, even though affective 
instability does not show specificity for BPD it might be the case that it can be used to predict symptom 
severity, psychopathology, or treatment outcome in BPD whereas it might be of minor relevance in other 
patient groups. Addressing the association between affective dysregulation and self-esteem instability or 
events and triggers of emotional episodes in patients with BPD and those with other psychiatric disorders 
constitute auspicious approaches for future studies in order to reveal specific patterns of symptom 
expression in BPD. 
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FIGURE LEGENDS 
Figure 1: Density plots based on the models applied in the Bayesian framework. The plots depict the 
distributions of the posterior mean estimations of the three coefficients corresponding to the components of 
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affective dysregulation with regard to distress and valence. Distributions of the respective coefficient 
estimates are shown for each investigated group separately for dataset 1 (patients with borderline personality 
disorder [BPD], those with posttraumatic stress disorder [PTSD], those with bulimia nervosa [BN] and 
healthy controls [HC]) and dataset 2 (patients with borderline personality disorder [BPD], those with panic 
disorder [PD], those with major depression [MD] and healthy controls [HC]). 
 
FIGURES 
Figures 1A, 1B, and 1C 
Figure 1A: Afective homebase
Figure 1B: Afective variability
Figure 1C: Atractor strength
Table 1. Demographic Characteristics of dataset 1 and dataset 2  
 Dataset 1 (N=119) Dataset 2 (N=142) 
 
 BPD (n=43) PTSD (n=28) BN (n=20) HC (n=28) BPD (n=51) PD (n=26) MD (n=25) HC (n=40) 
Age in years         
Mean (Sd) 26.7 (7.1) 35.25 (7.5) 23.70 (6.0) 28.82 (7.5) 27.1 (6.7) 33.1 (8.4) 34.1 (7.8) 27.8 (7.4) 
Sex         
% female 100 100 100 100 100 100 100 100 
Total number of e-diary data entries         
Mean (Sd) 57.91 (7.7) 58.50 (8.7) 56.70 (7.7) 56.68 (7.1) 26.3 (3.4) 24.5 (4.0) 23.5 (3.3) 26.0 (3.3) 
         
 BPD (n=43) PTSD (n=28) BN (n=20) BPD (n=51) PD (n=26) MD (n=25) 
Psychotropic medication 
n (%) 16 (37%) 17 (60%) 5 (25%) 22 (43%) 10 (39%) 24 (96%) 
Hospitalization 
Outpatients n (%) 26 (60%) 8 (29%) 9 (45%) 26 (51%) 21 (81%) 13 (52%) 
Inpatients n (%) 17 (40%) 20 (71%) 11 (55%) 25 (49%) 5 (19%) 12 (48%) 
Current Axis I diagnoses n (%) 
Major depression 9 (21%) 15 (54%) 10 (50%) 17 (33%) 4 (15%) 25 (100%) 
Anxiety disorders 27 (63%) 19 (68%) 10 (50%) 35 (69%) 26 (100%) 12 (48%) 
Generalized anxiety disorder 6 (14%) 1 (4%) 1 (5%) 8 (16%) 5 (19%) 4 (16%) 
Panic disorder 14 (33%) 10 (36%) 2 (10%) 13 (26%) 26 (100%) 2 (8%) 
Agora phobia 3 (7%) 0 (0%) 2 (10%) 4 (8%) 23 (89%) 1 (4%) 
Other phobias 20 (47%) 15 (54%) 9 (45%) 16 (31%) 5 (19%) 6 (24%) 
Posttraumatic stress disorder 22 (51%) 28(100%) 3 (15%) 7 (14%) 0 (0%) 6 (24%) 
Obsessive-compulsive disorder 5 (12%) 0 (0%) 1 (5%) 6 (12%) 0 (0%) 2 (8%) 
Eating disorders 14 (33%) 20 (71%) 20 (100%) 18 (35%) 0 (0%) 1 (4%) 
Current Axis II disorders n (%) 
Cluster A 7 (16%) 3 (11%) 1 (5%)    
Cluster B  
(besides BPD diagnosis) 
3 (7%) 0 (0%) 1 (5%)    
Cluster C 26 (61%) 8 (29%) 4 (20%)    
BPD = Borderline Personality Disorder; PTSD = Posttraumatic Stress Disorder; BN = Bulimia Nervosa; PD = Panic Disorder; MD = Major Depression; HC = Healthy Controls   
Table 2. Estimates from multilevel models for the three subcomponents of affective dysregulation with patients with borderline personality disorder as the reference group 
 Dataset 1   Dataset 2 
 Distress  Valence   Distress 
 
Coeff. SE 
Test 
statistic 
df p-value 
 
Coeff. SE 
Test 
statistic 
df 
p-
value 
  
Coeff. SE 
Test 
statistic 
df 
p-
value 
For HOMEBASE, π0             For HOMEBASE, π0      
Intercept, β00 4.91 0.284 17.28 86 <.001  -2.59 0.410 -6.33 88 <.001  Intercept, β00 4.66 0.275 16.92 97 <.001 
PTSDi, β01 -0.23 0.497 -0.46 86 .65  0.50 0.743 0.68 88 .50  PDi, β01 -2.06 0.373 -5.54 97 <.001 
BNi, β02 -0.71 0.552 -1.29 86 .20  1.43 0.759 1.88 88 .06  MDi, β02 -1.30 0.415 -3.15 97 <.001 
For VARIANCE             For VARIANCE      
Intercept, α0 1.22 0.032 38.32  <.001  3.14 0.031 99.65  <.001  Intercept, α0 1.05 0.044 23.90  <.001 
PTSDi, α1 -0.03 0.050 -0.70  .48  -0.06 0.049 -1.31  .19  PDi, α1 0.02 0.078 0.24  .81 
BNi, α2 0.19 0.056 3.41  <.001  0.08 0.056 1.44  .15  MDi, α2 0.09 0.084 1.12  .26 
For 
AUTOREGRESSIVE 
slope, π1 
            For 
AUTOREGRESSIVE 
slope, π1 
     
Intercept, β10 0.46 0.036 12.51 86 <.001  0.33 0.034 9.48 88 <.001  Intercept, β10 0.26 0.038 6.87 97 <.001 
PTSDi, β11 -0.02 0.052 -0.35 86 .73  0.04 0.056 0.63 88 .53  PDi, β11 -0.04 0.064 -0.58 97 .56 
BNi, β12 0.04 0.048 0.86 86 .39  -0.04 0.057 -0.71 88 .48  MDi, β12 0.08 0.076 1.09 97 .28 
PTSD = Posttraumatic Stress Disorder; BN = Bulimia Nervosa; PD = Panic Disorder; MD = Major Depression 
Bolded values = significant difference supported by the result of the multilevel model with Bayesian inference   
Table 3. Estimates from multilevel models for the three subcomponents of affective dysregulation with healthy controls as the reference group 
 Dataset 1   Dataset 2 
 Distress  Valence   Distress 
 
Coeff. SE 
Test 
statistic 
df p-value 
 
Coeff. SE 
Test 
statistic 
df 
p-
value 
  
Coeff. SE 
Test 
statistic 
df 
p-
value 
For HOMEBASE, π0             For HOMEBASE, π0      
Intercept, β00 0.47 0.114 4.10 107 <.001  1.53 0.233 6.58 117 <.001  Intercept, β00 0.58 0.094 6.24 131 <.001 
BPD+PTSD+BNi, β01 4.21 0.242 17.43 107 <.001  -3.65 0.389 -9.34 117 <.001  BPD+MD+PDi, β01 3.24 0.215 15.10 131 <.001 
For VARIANCE             For VARIANCE      
Intercept, α0 -0.24 0.045 -5.26  <.001  2.11 0.039 54.49  <.001  Intercept, α0 0.05 0.054 0.97  .33 
BPD+PTSD+BNi, α1 1.49 0.050 29.69  <.001  1.03 0.044 23.23  <.001  BPD+MD+PDi, α1 1.03 0.063 16.29  <.001 
For 
AUTOREGRESSIVE 
slope, π1 
            For 
AUTOREGRESSIVE 
slope, π1 
     
Intercept, β10 0.28 0.059 4.71 107 <.001  0.25 0.037 6.74 117 <.001  Intercept, β10 0.18 0.044 3.97 131 <.001 
BPD+PTSD+BNi, β11 0.18 0.063 2.89 107 <.01  0.07 0.044 1.69 117 .09  BPD+MD+PDi, β11 0.10 0.053 1.86 131 .07 
BPD = Borderline Personality Disorder; PTSD = Posttraumatic Stress Disorder; BN = Bulimia Nervosa; PD = Panic Disorder; MD = Major Depression 
Bolded values = significant difference supported by the result of the multilevel model with Bayesian inference 
